Contact
Please use this form to send email to PR contact of this press release:
Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
TO:
Please use this form to send email to PR contact of this press release:
Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
TO: